Tiotropium vs long‐acting beta‐agonists
Hospitalisations, number of participants with 1 or more exacerbations · patients with stable chronic obstructive pulmonary disease and > 10 pack years smoking history
Tiotropium probably leads to lower patients with 1 or more exacerbations compared with long‐acting beta‐agonists (moderate certainty).
1 finding from 1 review
- Tiotropium versus long‐acting beta‐agonists for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes onlyOR 0.86 [0.79, 0.93]6 studies · 12123 participantsModerate